These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24211780)

  • 21. IL-27 attenuates the TGF-β1-induced proliferation, differentiation and collagen synthesis in lung fibroblasts.
    Dong Z; Zhao X; Tai W; Lei W; Wang Y; Li Z; Zhang T
    Life Sci; 2016 Feb; 146():24-33. PubMed ID: 26776832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cells.
    Wang J; Tokoro T; Matsui K; Higa S; Kitajima I
    Life Sci; 2005 Mar; 76(19):2257-68. PubMed ID: 15733940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.
    Yang T; Chen M; Sun T
    Cell Physiol Biochem; 2013; 31(6):863-74. PubMed ID: 23817018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of doxycycline on production of growth factors and matrix metalloproteinases in pulmonary fibrosis.
    Fujita H; Sakamoto N; Ishimatsu Y; Kakugawa T; Hara S; Hara A; Amenomori M; Ishimoto H; Nagata T; Mukae H; Kohno S
    Respiration; 2011; 81(5):420-30. PubMed ID: 21502778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
    Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
    Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy.
    Tong BD; Xiao MY; Zeng JX; Xiong W
    Mol Vis; 2015; 21():324-34. PubMed ID: 25873777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of budesonide on TGF-beta1-enhanced VEGF production by lung fibroblasts.
    Chen YJ; Wang T; Liu DS; Xu D; Chen L; An J; Wen FQ
    Cell Biol Int; 2010 Jul; 34(7):777-82. PubMed ID: 20359293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxymatrine inhibits collagen synthesis in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Fan DL; Zhao WJ; Wang YX; Han SY; Guo S
    Int J Dermatol; 2012 Apr; 51(4):463-72. PubMed ID: 22435440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pitavastatin decreases the expression of endothelial lipase both in vitro and in vivo.
    Kojima Y; Ishida T; Sun L; Yasuda T; Toh R; Rikitake Y; Fukuda A; Kume N; Koshiyama H; Taniguchi A; Hirata K
    Cardiovasc Res; 2010 Jul; 87(2):385-93. PubMed ID: 20045866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
    Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NADPH oxidase-2 is a key regulator of human dermal fibroblasts: a potential therapeutic strategy for the treatment of skin fibrosis.
    Zhang GY; Wu LC; Dai T; Chen SY; Wang AY; Lin K; Lin DM; Yang JQ; Cheng B; Zhang L; Gao WY; Li ZJ
    Exp Dermatol; 2014 Sep; 23(9):639-44. PubMed ID: 24981855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.
    Schilter H; Cantemir-Stone CZ; Leksa V; Ohradanova-Repic A; Findlay AD; Deodhar M; Stockinger H; Song X; Molloy M; Marsh CB; Jarolimek W
    Immunol Lett; 2015 Jun; 165(2):90-101. PubMed ID: 25929803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cells.
    Kibayashi E; Urakaze M; Kobashi C; Kishida M; Takata M; Sato A; Yamazaki K; Kobayashi M
    Clin Sci (Lond); 2005 Jun; 108(6):515-21. PubMed ID: 15701058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PM
    Xu Z; Li Z; Liao Z; Gao S; Hua L; Ye X; Wang Y; Jiang S; Wang N; Zhou D; Deng X
    Ecotoxicol Environ Saf; 2019 Apr; 171():112-121. PubMed ID: 30597315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation.
    Kaneyuki U; Ueda S; Yamagishi S; Kato S; Fujimura T; Shibata R; Hayashida A; Yoshimura J; Kojiro M; Oshima K; Okuda S
    Vascul Pharmacol; 2007 Apr; 46(4):286-92. PubMed ID: 17178255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel HMG-CoA reductase inhibitor, Pitavastatin, induces a protective action in vascular endothelial cells through the production of nitric oxide (NO).
    Tokoro T; Wang J; Kitajima I
    Yakugaku Zasshi; 2004 Mar; 124(3):121-6. PubMed ID: 15049129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pin1 protein regulates Smad protein signaling and pulmonary fibrosis.
    Shen ZJ; Braun RK; Hu J; Xie Q; Chu H; Love RB; Stodola LA; Rosenthal LA; Szakaly RJ; Sorkness RL; Malter JS
    J Biol Chem; 2012 Jul; 287(28):23294-305. PubMed ID: 22613712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
    Song CY; Kim BC; Lee HS
    Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.